HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients
about
Immune response to HHV-6 and implications for immunotherapyHuman Herpesvirus-6 Encephalitis After Hematopoietic Stem Cell TransplantationEarly developmental outcomes of children with congenital HHV-6 infection.HHV-6 reactivation and associated sequelae after hematopoietic cell transplantationDiagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantationFrequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.Laboratory and clinical aspects of human herpesvirus 6 infections.Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantationIdentification of chromosomally integrated human herpesvirus 6 by droplet digital PCR.TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR.Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantationPersistent human herpesvirus-6 infection in patients with an inherited form of the virus.Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Chromosomally integrated human herpesvirus 6: questions and answers.Psychosocial care in cancer.Chromosomally integrated human herpesvirus-6 in transplant recipients.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis.Biomarkers of delirium as a clue to diagnosis and pathogenesis of Wernicke-Korsakoff syndrome.Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.Development of real-time RT-PCR assays for detection of three classes of HHV-6A gene transcripts.New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomib.Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation.HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.Human herpesvirus 6 is associated with status epilepticus and hyponatremia after umbilical cord blood transplantation.Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.Human herpesvirus-6 encephalitis following chemotherapy induction for acute myelogenous leukemia.Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.Specific CD8⁺ T cells recognize human herpesvirus 6B.
P2860
Q26827409-B9F32F00-CCA0-4627-9169-7A0F3721DF1EQ27010284-B1FEBCE9-EE69-4267-8F33-8DC85A7B6A84Q27345284-29179DDF-6049-4FA0-A477-B6C6FD18F763Q28727925-720FA321-E4A5-4691-985B-DC8BD1C951E4Q30883059-BF3AA3F2-99D1-48B3-8D85-DA1A79A4FCDEQ33559473-83C9AB62-837F-4B21-8203-781A7F6C22C3Q33897804-061390A0-741D-4B16-93E6-40C165EDA266Q34195389-9112903D-7127-4677-ADE8-6B82FD537EABQ34273968-C69042B4-CDBC-4253-8D2D-DE7156F9FDBBQ34537814-DC5A8241-3AE0-45EC-A62F-E69BD67524F6Q35482603-386721B6-58FA-468E-8A3D-F1BFABDF8BFEQ35752239-FAE966AE-85D9-41D6-B106-E859E5E8EE31Q35801310-46CB8F32-024C-4D42-81A6-2DE308197942Q35879617-EE53931D-5C17-44B4-989C-87AE9059D1F8Q36236659-A9BE5ED3-7C7E-4594-9007-D52C7FEAEB21Q36834718-75222015-D517-4940-B906-8BB5BEAFAB2DQ37006823-49053AED-6A3E-460A-9A89-39872DB9BCA6Q37189313-7353D771-EE31-496A-91EF-938B5D311847Q37276889-1398583E-CDC1-4A38-AE76-83284B392426Q37952634-F09C9477-5824-427E-B3AA-D247DE3CA6E9Q37954124-A9009856-969F-49BC-B73F-AA179C9DC0A6Q37982856-669E9AFF-2D88-45DE-968B-F6EB65A5C0DFQ38002109-2F13F477-77E4-457A-8D13-754B8B00A5B8Q38045704-B3E4D836-7E5A-4EAF-AA9B-AFC4788CCA88Q38116092-E7D9BA0B-2016-4035-845C-CAFDC00C95C3Q38256992-852552F1-4B4B-48A7-938E-87CD721938B8Q38444117-EE67FE6C-AD5E-4DD7-B9BF-E0088C6D9DB7Q40185839-99A967DC-461A-44BD-A5E4-F2506784710EQ40264216-BC52EB4B-A678-4F6B-9942-28BBAD734A48Q41021152-82BA4101-F544-491E-92A9-B493CE0D8A60Q41073087-317DDCB1-3587-4FA1-A907-9505604A4FF4Q41715322-46083E2F-9F2B-48C3-8B0D-E2A3091697EBQ43971471-CF79072A-1A45-45A5-B1CE-E2BCCEB3FE10Q44994852-2DD3C80C-830E-4AE3-882C-E73123C0D8F8Q48178536-C342ED43-3AE5-4805-99BB-ABAE1B9C04B8Q54252789-ACF4CC62-092C-4BF9-96DB-164F8A014E4BQ54296983-70B0A1C6-84BA-4CF1-8185-554361FEB5AD
P2860
HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HHV-6 reactivation and its eff ...... ell transplantation recipients
@ast
HHV-6 reactivation and its eff ...... ell transplantation recipients
@en
HHV-6 reactivation and its eff ...... ell transplantation recipients
@nl
type
label
HHV-6 reactivation and its eff ...... ell transplantation recipients
@ast
HHV-6 reactivation and its eff ...... ell transplantation recipients
@en
HHV-6 reactivation and its eff ...... ell transplantation recipients
@nl
prefLabel
HHV-6 reactivation and its eff ...... ell transplantation recipients
@ast
HHV-6 reactivation and its eff ...... ell transplantation recipients
@en
HHV-6 reactivation and its eff ...... ell transplantation recipients
@nl
P2093
P2860
P50
P1433
P1476
HHV-6 reactivation and its eff ...... ell transplantation recipients
@en
P2093
Amanda L Adler
Colleen Delaney
Danielle M Zerr
David Breiger
Jesse R Fann
Wendy M Leisenring
P2860
P304
P356
10.1182/BLOOD-2010-10-316083
P407
P577
2011-05-12T00:00:00Z